콘텐츠로 건너뛰기
Merck
모든 사진(1)

주요 문서

M-205

Supelco

Medazepam solution

1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

로그인조직 및 계약 가격 보기


About This Item

실험식(Hill 표기법):
C16H15ClN2
CAS Number:
Molecular Weight:
270.76
MDL number:
UNSPSC 코드:
41116107
NACRES:
NA.24

Grade

certified reference material

Quality Level

양식

liquid

특징

Snap-N-Spike®/Snap-N-Shoot®

포장

ampule of 1 mL

제조업체/상표

Cerilliant®

drug control

psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

농도

1 mg/mL in methanol

기술

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

응용 분야

clinical testing

형식

single component solution

저장 온도

−20°C

SMILES string

Clc1cc2c(cc1)N(CCN=C2c3ccccc3)C.Cl

InChI

1S/C16H15ClN2.ClH/c1-19-10-9-18-16(12-5-3-2-4-6-12)14-11-13(17)7-8-15(14)19;/h2-8,11H,9-10H2,1H3;1H

InChI key

XBWAZCLHZCFCGK-UHFFFAOYSA-N

일반 설명

Medazepam, marketed as Azepamid, Nobrium, Tranquirax, Rudotel, Raporan, Ansilan and Mezapam, is a long-acting benzodiazepine drug used as anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant. This certified solution standard is suitable for numerous GC/MS or LC/MS testing applications in forensic analysis, clinical toxicology, urine drug testing, or therapeutic drug monitoring.

법적 정보

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

픽토그램

FlameSkull and crossbonesHealth hazard

신호어

Danger

유해 및 위험 성명서

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

표적 기관

Eyes,Central nervous system

Storage Class Code

3 - Flammable liquids

WGK

WGK 2

Flash Point (°F)

51.8 °F - closed cup

Flash Point (°C)

11.0 °C - closed cup


가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 문서 section.

도움이 필요하시면 연락하세요. 고객 지원 부서

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Rio P Juni et al.
JACC. Basic to translational science, 4(5), 575-591 (2019-11-27)
The positive findings of the EMPA-REG OUTCOME trial (Randomized, Placebo-Controlled Cardiovascular Outcome Trial of Empagliflozin) on heart failure (HF) outcome in patients with type 2 diabetes mellitus suggest a direct effect of empagliflozin on the heart. These patients frequently have

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.